The biology and diagnostic applications of plasma RNA

Annals of the New York Academy of Sciences

Volumn 1022, Issue , 2004, Pages 135-139

  Lo, Y M Dennis ^a   Chiu, Rossa W K ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Circulating RNA; Plasma RNA; Prenatal diagnosis

Indexed keywords

RNA;

BLOOD ANALYSIS; CELL FREE SYSTEM; CONFERENCE PAPER; DIAGNOSTIC VALUE; FETUS BLOOD; FETUS MONITORING; HUMAN; MATERNAL PLASMA; MOLECULAR BIOLOGY; PLACENTA; PRENATAL DIAGNOSIS; QUANTITATIVE ANALYSIS; RNA ANALYSIS; RNA EXTRACTION;

EID: 3242659751     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1318.022     Document Type: Conference Paper

References (31)

1. LO, Y.M.D. 2001. Circulating nucleic acids in plasma and serum: an overview. Ann. N.Y. Acad. Sci. 945: 1-7.
2. ANKER, P. & M. STROUN. 2001. Tumor-related alterations in circulating DNA, potential for diagnosis, prognosis and detection of minimal residual disease. Leukemia 15: 289-291.
3. WONG, I.H. et al. 1999. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Res. 59: 71-73.
4. LO, Y.M.D. et al. 1997. Presence of fetal DNA in maternal plasma and serum. Lancet. 350: 485-487.
5. CHIU, R.W.K. et al. 2002. Prenatal exclusion of beta-thalassaemia major by examination of maternal plasma. Lancet 360: 998-1000.
6. LO, Y.M.D. et al. 1998. Presence of donor-specific DNA in plasma of kidney and liver-transplant recipients. Lancet 351: 1329-1330.
7. CHEN, X.Q. et al. 1996. Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat. Med. 2: 1033-1035.
8. LO, K.W. et al. 1999. Analysis of cell-free Epstein-Barr virus associated RNA in the plasma of patients with nasopharyngeal carcinoma. Clin. Chem. 45: 1292-1294.
9. KOPRESKI, M. et al. 1999. Detection of tumor messenger RNA in the serum of patients with malignant melanoma. Clin. Cancer Res. 5: 1961-1965.
10. CHEN, X.Q. et al. 2000. Telomerase RNA as a detection marker in the serum of breast cancer patients. Clin. Cancer Res. 6: 3823-3826.
11. DASI, F. et al. 2001. Real-time quantification in plasma of human telomerase reverse transcriptase (hTERT) mRNA: a simple blood test to monitor disease in cancer patients. Lab. Invest. 81: 767-769.
12. NOVAKOVIC, S. et al. 2004. Detection of telomerase RNA in the plasma of patients with breast cancer, malignant melanoma or thyroid cancer. Oncol. Rep. 11: 245-252.
13. MIURA, N. et al. 2003. Sensitive detection of human telomerase reverse transcriptase mRNA in the serum of patients with hepatocellular carcinoma. Oncology 64: 430-434.
14. SILVA, J.M. et al. 2001. Detection of epithelial messenger RNA in the plasma of breast cancer patients is associated with poor prognosis tumor characteristics. Clin. Cancer Res. 7: 2821-2825.
15. GAL, S. et al. 2001. Detection of mammaglobin mRNA in the plasma of breast cancer patients. Ann. N.Y. Acad. Sci. 945: 192-194.
16. WONG, S.C.C. et al. 2004. Quantification of plasma catenin mRNA in colorectal cancer and adenoma patients. Clin. Cancer Res. 10: 1613-1617.
17. NG, E.K.O. et al. 2002. Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals. Clin. Chem. 48: 1212-1217.
18. TSUI, N.B.Y, E.K.O. NG & Y.M.D. LO. 2002. Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clin. Chem. 48: 1647-1653.
19. HASSELMANN, D.O. et al. 2001. Extracellular tyrosinase mRNA within apoptotic bodies is protected from degradation in human serum. Clin. Chem. 47: 1488-1489.
20. JAHR, S. et al. 2001. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res. 61: 1659-1665.
21. POON, L.L.M. et al. 2000. Presence of fetal RNA in maternal plasma. Clin. Chem. 46: 1832-1834.
22. NG, E.K.O. et al. 2003. mRNA of placental origin is readily detectable in maternal plasma. Proc. Natl. Acad. Sci. USA 100: 4748-4753.
23. NG, E.K.O. et al. 2003. The concentration of circulating corticotropin-releasing hormone mRNA in maternal plasma is increased in preeclampsia. Clin. Chem. 49: 727-731.
24. OUDEJANS, C.B. et al. 2003. Detection of chromosome 21-encoded mRNA of placental origin in maternal plasma. Clin. Chem. 49: 1445-1449.
25. WATAGANARA, T. et al. 2003. Gamma-globin gene expression levels in archived maternal plasma following elective first trimester termination of pregnancy. Clin. Chem. 49: 1968.
26. TSUI, N.B.Y. et al. 2004. Systematic microarray-based identification of placental mRNA in maternal plasma: towards non-invasive prenatal gene expression profiling. J. Med. Genet. In press.
27. LUI, Y.Y.N. et al. 2002. Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation. Clin. Chem. 48: 421-427.
28. LUI, Y.Y.N. et al. 2003. Origin of plasma cell-free DNA after solid organ transplantation. Clin. Chem. 49: 495-496.
29. LO, Y.M.D. et al. 2000. Plasma DNA as a prognostic marker in trauma patients. Clin. Chem. 46: 319-323.
30. RAINER, T.H. et al. 2003. Prognostic use of circulating plasma nucleic acid concentrations in patients with acute stroke. Clin. Chem. 49: 562-569.
31. RAINER, T.H. et al. 2004. Effects of filtration on glyceraldehyde-3- phosphate dehydrogenase mRNA in the plasma of trauma patients and healthy individuals. Clin. Chem. 50: 206-208.